PRISM BioLab Co.,LTD (TYO:206A)
Japan · Delayed Price · Currency is JPY 160.00
-3.00 (-1.84%)
Aug 6, 2026, 1:46 PM JST
PRISM BioLab Co.,LTD Market Cap
PRISM BioLab Co.,LTD has a market cap or net worth of 6.03 billion as of August 5, 2026. Its market cap has decreased by -6.11% in one year.
Market Cap
6.03B
Enterprise Value
3.57B
Revenue
711.65M
Ranking
n/a
PE Ratio
n/a
Stock Price
160.00
ChartMarket Cap Chart
Since July 2, 2024, PRISM BioLab Co.,LTD's market cap has decreased from 17.84B to 6.03B, a decrease of -66.23%. That is a compound annual growth rate of -40.43%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 6, 2026 | 6.03B | 4.62% |
| Dec 30, 2025 | 5.76B | -44.77% |
| Dec 30, 2024 | 10.43B | -41.56% |
| Jul 2, 2024 | 17.84B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Kidswell Bio | 7.25B |
| ADR Biomedical Holdings | 7.06B |
| MEDINET | 7.04B |
| BrightPath Biotherapeutics | 6.67B |
| Carna Biosciences | 6.25B |
| CellSource | 6.15B |
| Chordia Therapeutics | 6.03B |
| Noile-Immune Biotech | 5.90B |